Strive Inc

Strive Inc(ASST)の株式分析

$21.740

-1.298 (-5.97%)終値時点

Loading chart…
High
23.590
Open
22.500
VWAP
22.24
Vol
11.77M
Mkt Cap
5.54M
Low
21.390
Amount
261.82M
EV/EBITDA, TTM
-1.88

Strive, Inc. is an asset management Bitcoin treasury company. The Company is focused on increasing Bitcoin per share to outperform Bitcoin over the long run. The Company's subsidiary, Strive Asset Management, LLC, is a SEC-registered investment adviser, which has assets under management (AUM) across approximately 13 exchange-traded funds, collective investment trusts, and a direct indexing platform. In addition, the Company owns Semler Scientific, Inc., a healthcare technology subsidiary focused on early disease detection products. Through its healthcare businesses, Semler Scientific and its wholly-owned subsidiary, CardioVanta, Inc. develop and market products and services for early detection and monitoring of chronic diseases. Semler Scientific's flagship product, QuantaFlo, provides rapid point-of-care testing to measure arterial blood flow in the extremities. The QuantaFlo test aids in the diagnosis of peripheral arterial disease.

AI analysis of Strive Inc (ASST)

buy

Given the current price of $21.74, the RSI at 76.558 indicates that the stock is in a strong bullish momentum. The forward P/E ratio of 3.0102 suggests that the stock is undervalued compared to its earnings potential. Additionally, the recent insider purchase of 15,900 shares by Director Pierre Rochard signals confidence in the company's future. However, the main risk is the significant year-over-year decline of 83.17%, indicating volatility and potential uncertainty in the stock's recovery.

バリュエーション指標

The current forward P/E ratio for Strive Inc (ASST) is 3.01, compared to its 5-year average forward P/E of 0.16.

Forward P/E

Strongly Overvalued
5Y Average P/E
0.16
Current P/E
3.01
割高
0.61
割安
-0.29

Forward EV/EBITDA

Strongly Undervalued
5Y Average EV/EBITDA
-0.15
Current EV/EBITDA
-1.88
割高
0.18
割安
-0.49

Forward P/S

Strongly Overvalued
5Y Average P/S
16.46
Current P/S
171.94
割高
52.37
割安
-19.46

Alphio AI Price Scenarios for ASST

Scenario prices are the last monthly forecast band of the current year. Probabilities are fixed model weights (25 / 50 / 25), not guarantees.

B

Bull

Bull · 25%ASST

$4.95

シナリオ価格

B

Base

Base · 50%ASST

$4.03

シナリオ価格

B

Bear

Bear · 25%ASST

$3.70

シナリオ価格

Whales holding ASST

A

Alpine Associates Management Inc.

+ HoldingASST

+3.01%

3M Return

イベントタイムライン

2026-08-28 (ET)

11:00:00

Bitcoin Options Expiry Removes $80,000 Support

2026-07-24 (ET)

10:30:00

U.S. Senators Release Draft of Cryptocurrency Clarity Act

2026-07-13 (ET)

09:00:00

Strive Acquires 18 Bitcoins at Average Price of Approximately $64,028

ニュース

ASST FAQ — answered by Alphio AI

Strive, Inc. is an asset management Bitcoin treasury company. The Company is focused on increasing Bitcoin per share to outperform Bitcoin over the long run. The Company's subsidiary, Strive Asset Management, LLC, is a SEC-registered investment adviser, which has assets under management (AUM) across approximately 13 exchange-traded funds, collective investment trusts, and a direct indexing platform. In addition, the Company owns Semler Scientific, Inc., a healthcare technology subsidiary focused on early disease detection products. Through its healthcare businesses, Semler Scientific and its wholly-owned subsidiary, CardioVanta, Inc. develop and market products and services for early detection and monitoring of chronic diseases. Semler Scientific's flagship product, QuantaFlo, provides rapid point-of-care testing to measure arterial blood flow in the extremities. The QuantaFlo test aids in the diagnosis of peripheral arterial disease. It operates in the Financials sector (SERVICES-PREPACKAGED SOFTWARE industry).

Given the current price of $21.74, the RSI at 76.558 indicates that the stock is in a strong bullish momentum. The forward P/E ratio of 3.0102 suggests that the stock is undervalued compared to its earnings potential. Additionally, the recent insider purchase of 15,900 shares by Director Pierre Rochard signals confidence in the company's future. However, the main risk is the significant year-over-year decline of 83.17%, indicating volatility and potential uncertainty in the stock's recovery.

本ページは調査目的であり、投資助言ではありません。モデルは誤ることがあります。過去の実績は将来の成果を保証しません。

無料で始める